Dear Colleagues,
On behalf of the Emirates Oncology Society, we would like to invite you delegates, esteemed faculty, committees, industry partners and friends to the Middle East’s First Transplant Oncology Conference, scheduled to take place on Saturday May 20th, 2023.
Transplant oncology is a novel concept that combines the fields of transplantation medicine oncology to advance hepatobiliary cancer therapy and research. This symposium brings together specialists and opinion leaders from across the world in transplant oncology, radiology, surgery, hepatology, and immunology to debate the boundaries and prospects of the multidisciplinary care of hepatobiliary malignancies.
- Liver transplantation for hepatocellular carcinoma, cholangiocarcinoma, colorectal, and neuroendocrine liver metastases
- Cancer recurrence after liver transplantation
- The role of novel chemotherapeutic and biological therapy agents in improving transplantation outcomes
- Applications of ctDNA in the field of Transplant Oncology
With Best Regards,
Humaid Al Shamsi, MD(HON), MRCP(UK), FRCP(C), FACP
Maen AbdelRahim, MD, PhD, Pharm.B
Dear Colleagues,
On behalf of the Emirates Oncology Society, we would like to invite you delegates, esteemed faculty, committees, industry partners and friends to the Middle East’s First Transplant Oncology Conference, scheduled to take place on Saturday May 20th, 2023.
Transplant oncology is a novel concept that combines the fields of transplantation medicine oncology to advance hepatobiliary cancer therapy and research. This symposium brings together specialists and opinion leaders from across the world in transplant oncology, radiology, surgery, hepatology, and immunology to debate the boundaries and prospects of the multidisciplinary care of hepatobiliary malignancies.
- Liver transplantation for hepatocellular carcinoma, cholangiocarcinoma, colorectal, and neuroendocrine liver metastases
- Cancer recurrence after liver transplantation
- The role of novel chemotherapeutic and biological therapy agents in improving transplantation outcomes
- Applications of ctDNA in the field of Transplant Oncology
With Best Regards,
Humaid Al Shamsi, MD(HON), MRCP(UK), FRCP(C), FACP
Maen AbdelRahim, MD, PhD, Pharm.B
Dear Colleagues,
On behalf of the Emirates Oncology Society, we would like to invite you delegates, esteemed faculty, committees, industry partners and friends to the Middle East’s First Transplant Oncology Conference, scheduled to take place on Saturday May 20th, 2023.
Transplant oncology is a novel concept that combines the fields of transplantation medicine oncology to advance hepatobiliary cancer therapy and research. This symposium brings together specialists and opinion leaders from across the world in transplant oncology, radiology, surgery, hepatology, and immunology to debate the boundaries and prospects of the multidisciplinary care of hepatobiliary malignancies.
- Liver transplantation for hepatocellular carcinoma, cholangiocarcinoma, colorectal, and neuroendocrine liver metastases
- Cancer recurrence after liver transplantation
- The role of novel chemotherapeutic and biological therapy agents in improving transplantation outcomes
- Applications of ctDNA in the field of Transplant Oncology
With Best Regards,
Humaid Al Shamsi, MD(HON), MRCP(UK), FRCP(C), FACP
Maen AbdelRahim, MD, PhD, Pharm.B
Akhbar Al Emarat | أخبار الإمارات
